Kancera Logo

Kancera

Pharmaceutical company seeking a reverse takeover to leverage its public listing.

KAN | ST

Overview

Corporate Details

ISIN(s):
SE0015658570 (+1 more)
LEI:
5493002P3RCOFW6HI207
Country:
Sweden
Address:
Nanna Svartz väg 4, 171 65 SOLNA

Description

Novakand Pharma AB, formerly Kancera AB, is a pharmaceutical company that was focused on the development of small molecule therapeutics. Its primary research areas included cancer and inflammatory diseases. The company's pipeline featured drug candidates targeting the fractalkine system for cardiovascular and inflammatory conditions, as well as ROR inhibitors for oncology applications such as leukemia and solid tumors. Following a strategic review prompted by challenging capital market conditions, the company has initiated a process to seek a reverse takeover, aiming to leverage its public listing and cash assets for a merger with another entity.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Kancera filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kancera

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kancera via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Urteste S.A. Logo
Develops non-invasive urine tests for the early detection of multiple cancers.
Poland
URT
VALIRX PLC Logo
Life science company developing therapeutics for oncology and women's health.
United Kingdom
VAL
Vera Therapeutics, Inc. Logo
Clinical-stage biotech developing treatments for immunological and rare diseases.
United States of America
VERA
ViGenCell Inc. Logo
Develops immune cell therapies to treat cancer and other incurable diseases.
South Korea
308080
Viking Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapies for metabolic and endocrine disorders.
United States of America
VKTX
Vinext S.p.A. Logo
Develops sustainable technology for the oenology and agri-food sectors.
Italy
VNXT
Virax Biolabs Group Ltd Logo
Biotechnology company specializing in immune response detection and viral disease diagnosis.
United States of America
VRAX
Viridian Therapeutics, Inc.\DE Logo
Develops antibody-based therapies for serious and rare autoimmune diseases.
United States of America
VRDN
VivoSim Labs, INC. Logo
Develops 3D bioprinted human tissues for non-animal drug toxicology testing.
United States of America
VIVS
VOLITIONRX LTD Logo
Epigenetics company developing blood tests for early diagnosis of cancer and sepsis.
United States of America
VNRX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.